ClinConnect ClinConnect Logo
Search / Trial NCT06465511

Supportive Clinic for Patients Living With Advanced and Metastatic Cancers

Launched by THE UNIVERSITY OF HONG KONG · Jun 17, 2024

Trial Information

Current as of August 21, 2025

Not yet recruiting

Keywords

Physical Symptom Distress Self Efficacy In Managing Cancer Health Related Quality Of Life Survivorship Intervention Advanced Cancer Randomised Controlled Trial Psychooncology

ClinConnect Summary

This clinical trial is looking at how a special supportive care program can help people living with advanced or metastatic cancer. The goal is to see if this program can improve patients' experiences, especially in terms of their physical symptoms and overall quality of life. Researchers want to find out if this program is effective and acceptable, which means they will check how well it works for patients and if they like it.

To participate, you need to be at least 18 years old and have been diagnosed with advanced or metastatic cancer. You should also be able to physically attend the supportive clinic. Unfortunately, if you don’t speak Cantonese, Mandarin, or English, you won’t be able to join this study. While the trial is not yet recruiting participants, those who do take part can expect to engage with a supportive environment designed to help manage their symptoms and improve their well-being.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients diagnosed with advanced or metastatic cancer
  • are at least 18 years of age
  • physically able to attend the supportive clinic.
  • Exclusion Criteria:
  • Participants will be excluded from the study if they are non-Cantonese-, non-Mandarin-, or non-English-speakers.

About The University Of Hong Kong

The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.

Locations

Hong Kong, , Hong Kong

Hong Kong, , Hong Kong

Hong Kong, , Hong Kong

Hong Kong, , Hong Kong

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Trial Officials

Wendy Lam, Phd

Principal Investigator

School of Public Health, The University of Hong Kong

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported